NCT00104949View on ClinicalTrials.gov

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

August 31, 2007

Conditions
Sarcoma
Interventions
BIOLOGICAL

trastuzumab

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK

NCT00104949 - Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | Biotech Hunter | Biotech Hunter